caffeine and atl 146e

caffeine has been researched along with atl 146e in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Lera Ruiz, M; Lim, YH; Zheng, J	1
Beller, GA; Glover, DK; Linden, J; Macdonald, TL; Rieger, JM; Riou, LM; Ruiz, M; Watson, DD	1

Reviews

1 review(s) available for caffeine and atl 146e

Article	Year
Adenosine A2A receptor as a drug discovery target. Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction	2014

Other Studies

1 other study(ies) available for caffeine and atl 146e

Article	Year
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. Journal of the American College of Cardiology, 2002, Nov-06, Volume: 40, Issue:9 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Caffeine; Calcium Channel Blockers; Coronary Circulation; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dogs; Enalaprilat; Hemodynamics; Phosphodiesterase Inhibitors; Propranolol; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilation; Verapamil	2002

Article

Year

Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.

Journal of the American College of Cardiology, 2002, Nov-06, Volume: 40, Issue:9

Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Caffeine; Calcium Channel Blockers; Coronary Circulation; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dogs; Enalaprilat; Hemodynamics; Phosphodiesterase Inhibitors; Propranolol; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilation; Verapamil

2002